megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering

@inproceedings{Boissel2014megaTALsAR,
  title={megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering},
  author={Sandrine J. S. Boissel and Jordan Jarjour and Alexander Astrakhan and Andrew C Adey and Agn{\`e}s Gouble and Philippe Duchateau and Jay Shendure and Barry L. Stoddard and Michael T. Certo and David P. Baker and Andrew M Scharenberg},
  booktitle={Nucleic acids research},
  year={2014}
}
Rare-cleaving endonucleases have emerged as important tools for making targeted genome modifications. While multiple platforms are now available to generate reagents for research applications, each existing platform has significant limitations in one or more of three key properties necessary for therapeutic application: efficiency of cleavage at the desired target site, specificity of cleavage (i.e. rate of cleavage at 'off-target' sites), and efficient/facile means for delivery to desired… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 7 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 56 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 46 references

Similar Papers

Loading similar papers…